UNSPSC 85532046: Supplement right femoral vein with nonautologous tissue substitute, percutaneous endoscopic approach

This classification denotes the group of activities that yields a surgical intervention or procedure to supplement right femoral vein with nonautologous tissue substitute, percutaneous endoscopic approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 06UM4KZ

UNSPSC 85532046, Supplement right femoral vein with nonautologous tissue substitute, percutaneous endoscopic approach, is a Commodity code that shows little relevant recent activity under state and local procurement. The code describes a specific surgical procedure — vascular supplementation of the right femoral vein using nonautologous tissue via percutaneous endoscopic technique — yet none of the six recent state and local contract opportunities posted in the source material involve procurement of this medical procedure or related implantable supplies. Instead, the opportunities span occupational medical surveillance services, pharmacy benefit management, temporary health professional staffing qualification pools, surgical benefits carve-out program design, independent medical evaluations for pension disability determinations, and emergency medical services for youth in detention. These are health services, insurance administration, and staffing arrangements rather than a procurement of a specific surgical intervention or vascular device. The mismatch suggests either that the code was misapplied to one or more of these opportunities in source data, or that state and local procurement activity under this Commodity code is currently inactive or tagged under alternative codes.

The source records do not identify any recent state and local solicitation expressly seeking right femoral vein supplementation procedures or related surgical implant materials under UNSPSC 85532046. Given the absence of aligned opportunity records over the most recent quarter of 2026, the code does not present actionable procurement signals at this time.